3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 2
1
Status
Completed
4
Unknown
2
Terminated
2
Active not recruiting
2
Withdrawn
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Myelodysplastic Syndromes
5
Lymphoma, Non-Hodgkin
5
Leukemia
5
Hodgkin Disease
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma
4
Leukemia, Myeloid, Chronic-Phase
4
Leukemia, Myeloid, Acute
4
Leukemia, Myeloid, Accelerated Phase
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Neoplasms, Plasma Cell
3
Multiple Myeloma
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, Follicular
3
Graft vs Host Disease
3
Congenital Abnormalities
3
Recurrence
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms
2
Myasthenia Gravis
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, B-Cell, Marginal Zone
2
Immunoblastic Lymphadenopathy
2
Hematologic Neoplasms
2
Dendritic Cell Sarcoma, Interdigitating
2
Burkitt Lymphoma
2
Blast Crisis
2
Interventions
Exercise
19
Drug Therapy
18
pembrolizumab
13
Capecitabine
11
Blood Specimen Collection
11
Surveys and Questionnaires
10
Radiotherapy
10
Paclitaxel
9
Dexamethasone
9
Nivolumab
8
Standard of Care
7
Oxaliplatin
7
Fluorouracil
7
Erlotinib Hydrochloride
7
apatinib
6
Interviews as Topic
6
Gemcitabine
6
Control Groups
6
Cisplatin
6
Therapeutics
5
Neoadjuvant Therapy
5
Mindfulness-Based Cognitive Therapy
5
Metformin
5
Injections
5
Everolimus
5
Docetaxel
5
Cyclophosphamide
5
Bevacizumab
5
sintilimab
4
atezolizumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Neoplasms
×
Mycophenolic Acid
×
Clear all
NCT04810156
2022-12-14
I-HEP
Herlev Hospital
Phase 2
Unknown
60 enrolled
NCT00903188
2009-05-18
CISTCERT
University Hospital, Antwerp
Phase 4
Unknown
152 enrolled